The market and medical innovation: Human passions and medical advancement

Journal of Medicine and Philosophy

Volumn 30, Issue 6, 2005, Pages 555-569

  Cherry, Mark J ^a  

^a ST EDWARD'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRUISM; CONFLICT OF INTEREST; DEVICE; DRUG RESEARCH; ECONOMICS; HEALTH CARE; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH SERVICE; MARKETING; MEDICAL INSTRUMENTATION; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PROFESSIONALISM; PROFIT; REVIEW; SCIENCE;

ANALYTICAL APPROACH; BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE AND PUBLIC HEALTH;

BIOETHICS; BIOMEDICAL RESEARCH; COMMERCE; CONFLICT OF INTEREST; DIFFUSION OF INNOVATION; DRUG INDUSTRY; ECONOMIC COMPETITION; HUMANS; PHILOSOPHY, MEDICAL; SOCIAL JUSTICE; TECHNOLOGY;

EID: 30544433190     PISSN: 03605310     EISSN: None     Source Type: Journal    
DOI: 10.1080/03605310500421363     Document Type: Review

References (42)

1. Andrews, L.B. (2000, March 10). Money is putting people at risk in biomedical research. Chronicle of Higher Education, 46(27), B4.
2. Angell, M. (2000). Is academic medicine for sale?. The New England Journal of Medicine, 342(20), 1516-1518.
3. Annas, G. (1991). Ethics committees: From ethical comfort to ethical cover. Hastings Center Report, 21, 18.
4. Association of University Technology Managers. (2003). The AUTM Licensing Survey: FY 2002. [On-line]. Available http://www.autm.net. Accessed: August 15, 2005.
5. Barnes, M., & Florencio, P. (2002). Investigator, IRB and institutional financial conflicts of interest in human-subjects research: Past, present and future. Seton Hall Law Review, 32, 525-561.
6. Bell, R. (1992). Impure science. New York: John Wiley & Sons, Inc.
7. Berlinguer, G., & De Castro, L. (2003, June 13). Report of the IBC on the possibility of elaborating a universal instrument on Bioethics. International Bioethics Committee, United Nations, Educational, Scientific and Cultural Organisation, Paris, France.
8. Blumenthal, D., Campbell, E.G., Causino, N., & Louis, K.S. (1996). Participation of life-science faculty in research relationships with industry. New England Journal of Medicine, 335, 1734-1739.
9. Blumenthal, D., Gluck, M. Louis, K.S., Stoto, M.A., & Wise, A. (1986). University industry research relationships in biotechnology: Implications for the university. Science, 232, 1361-1366.
10. Brody, B.A. (1996). Conflicts of interests and the validity of clinical trials. In R.G. Spece, Jr., D.S. Shimm & A. Buchanan (eds.), Conflicts of interest in clinical practice and research (pp. 407-417). New York: Oxford University Press.
11. Campbell, E.G., Weissman, J.S., May, E., & Blumenthal, D. (2001). Status of clinical research in academic health centers: Views from research leadership. Journal of the American Medical Association, 286(7), 800-806.
12. Capaldi, N. (2005). The ethics and economics of healthcare. The Journal of Medicine and Philosophy, 30(6), 571-578.
13. Cave, E., & Holm, S. (2002). New governance arrangements for research ethics committees: Is facilitating research achieved at the cost of participants' interest. Journal of Medical Ethics, 28, 318-321.
14. Cherry, M. (2005). Kidney for sale by owner: Human organs, transplantation, and the market. Washington, DC: Georgetown University Press.
15. Cho, M., Shohara, R., Schissel, A., & Drummond, R. (2000). Policies on faculty conflicts of interest at US universities. Journal of the American Medical Association, 284(17), 2203-2208.
16. Christian, M., Goldberg, J., Killen, J., Abrams, J., McCabe, M., Mauer, J., & Wittes, R. (2002). A central institutional review board for multi-institutional trials. New England Journal of Medicine, 346(18), 1405-1408.
17. Council on Governmental Relations. (1999). The Bayh-Dole Act: A guide to the law and implementing regulations. [On-line]. Available www.ucop.edu/ott/ bayh.html. Accessed: August 15, 2005.
18. Culliton, B.J. (1981). Biomedical research enters the marketplace. New England Journal of Medicine, 304, 1195-1201.
19. DeAngelis, C.D., Drazen, J.M., Frizelle, F.A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A.J., Schroeder, T.V., & Van der Weyden, M.B. (2004). Clinical trial registration: A statement from the international committee of medical journal editors. Journal of the American Medical Association, 292(11), 1363-1364.
20. Engelhardt, H.T., Jr. (1996). The foundations of bioethics, 2nd ed. New York: Oxford University Press.
21. Fenton, E., & Lomasky, L. (2005). Dispensing with liberty: Conscientious refusal and the "morning after pill." The Journal of Medicine and Philosophy, 30(6), 579-592.
22. Forster, D. (2002). New directions in human subject research: Looking beyond the academic medical center: Independent Review Boards. Seton Hall Law Review, 32, 513-523.
23. Francis, L. (1996). IRBs and conflicts of interest. In R.G. Spece, Jr., D.S. Shimm & A. Buchanan (eds.), Conflicts of interest in clinical practice and research (pp. 418-436). New York: Oxford University Press.
24. Friedberg, M., Saffran, B., Stinson, T., Nelson, W., & Bennett, C. (1999). Evaluation of conflict of interest in economic analyses of new drugs used on oncology. Journal of the American Medical Association, 282(15), 1453-1457.
25. Goodman, T. (2005). Is there a right to health?. The Journal of Medicine and Philosophy, 30(6), 643-662.
26. Hasselmo, N. (2002). Individual and institutional conflict of interest: Policy review by research universities in the United States. Science and Engineering Ethics, 8(3), 421-427.
27. Hippen, B. (2005). In defense of a regulated market in kidneys from living vendors. The Journal of Medicine and Philosophy, 30(6), 593-626.
28. Lee, S., Ralston, H.J.P., Drey, E.A., Partridge, J.C., & Rosen, M.A. (2005). Fetal pain: A systematic multidisciplinary review of the evidence. Journal of the American Medical Association, 294, 947-954.
29. Lemmens, T., & Freedman, B. (2000). Ethics review for sale? Conflict of interest and commercial research review boards. Milbank Quarterly, 78(4), 547-583.
30. Lemmens, T., & Thompson, A. (2001). Non institutional commercial review boards in North America. IRB: Ethics and Human Research, 23(2), 1-12.
31. Lichtenberg, F.R. (1996). The effect of pharmaceutical utilization and innovation on hospitalization and mortality. National Bureau of Economic Research Working Paper, 541, 8.
32. Lichtenberg, F.R. (2005). Pharmaceutical innovation and the burden of disease in developing and developed countries. The Journal of Medicine and Philosophy, 30(6), 663-690.
33. Lo, B., Wolf, L., & Berkeley, A. (2000). Conflict-of-interest policies for investigators in clinical trials. The New England Journal of Medicine, 343(22), 1616-1620.
34. Office of Research Integrity. (2000). Responsibility of applicants for promoting objectivity in research for which PHS funding is sought. 42 C.F.R. 50, 601-607.
35. O'Toole, M. (1991). Magot O'Toole's record of events. Nature, 351, 183.
36. Petratos, P. (2005). Does the private finance initiative promote innovation in healthcare? The case of the British National Health Service. The Journal of Medicine and Philosophy, 30(6), 627-642.
37. Pharma. (2004). The issues: intellectual property. [On-line]. Available: www. pharma.org. Accessed: 6/24/04.
38. Rabino, I. (1998). Societal and commercial issues affecting the future of biotechnology in the United States: a survey of researchers' perceptions. Naturwissenschaften, 85, 109-116.
39. Rosenberg, N., & Birdzell, L.E., Jr. (2002). How the West grew rich: The economic transformation of the industrial world. In E. Heath (ed.), Morality and the market: Ethics and virtue in the conduct of business (pp. 10-24). New York: McGraw-Hill.
40. Senate Joint Economics Committee (2000) The benefits of medical research and the role of the NIH, May 2000. Available http://jec.senate.gov.
41. Shimm, D.S., & Spece, R.G., Jr. (1996). An introduction to conflicts of interest in clinical research. In R.G. Spece, Jr., D.S. Shimm & A. Buchanan (eds.), Conflicts of interest in clinical practice and research (pp. 361-375). New York: Oxford University Press.
42. Slater, E.E. (2002). IRB reform. New England Journal of Medicine, 346(18), 1402-1404.